Arrowgrass Capital Partners (US) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$48.2M |
| 2 |
LyondellBasell Industries
LYB
|
+$46.7M |
| 3 |
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
|
+$33.8M |
| 4 |
Darling Ingredients
DAR
|
+$33.3M |
| 5 |
American Airlines Group
AAL
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$246M |
| 2 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$163M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$46.5M |
| 4 |
SPRD
SPREADTRUM COMMUNICATIONS INC ADS (CAYMAN ISLANDS)
SPRD
|
+$44.4M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$34.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 5.69% |
| 2 | Healthcare | 5.33% |
| 3 | Financials | 5.13% |
| 4 | Consumer Discretionary | 4.8% |
| 5 | Technology | 4.68% |
Similar funds
Arrowgrass Capital Partners (US)'s Q4 2013 Portfolio in Review
As of Q4 2013, Arrowgrass Capital Partners (US) held 246 positions worth $2.13B, down 20% from $2.67B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arrowgrass Capital Partners (US) withdrew a net $1.03B in Q4 2013, closing 93 positions and reducing 30 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 5.7% of assets, up from 1.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Arrowgrass Capital Partners (US) opened a new position in TIME WARNER CABLE INC NEW COM STK worth $52.6M.
- Arrowgrass Capital Partners (US)'s largest Q4 2013 buy was TIME WARNER CABLE INC NEW COM STK: 387,871 shares worth $52.6M.
- Arrowgrass Capital Partners (US) added most to HEALTH MGMT ASSOC INC CL-A in Q4 2013, an estimated $33.8M increase.
- Arrowgrass Capital Partners (US)'s biggest Q4 2013 reduction was LIFE TECHNOLOGIES CORP COM STK (DE), cutting an estimated $46.5M.
- Arrowgrass Capital Partners (US) fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $246M.
- Arrowgrass Capital Partners (US)'s ten largest holdings make up 37% of its $2.13B portfolio in Q4 2013.
- Arrowgrass Capital Partners (US) opened 69 new positions and closed 93 in Q4 2013.
- Arrowgrass Capital Partners (US)'s portfolio value fell 20% quarter-over-quarter to $2.13B.
Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2013, filed 14 Feb 2014.